{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-030306","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2026-06-26T20:30:19+00:00","discovered_at":"2026-06-26T20:31:00.598180+00:00","generated_at":"2026-06-26T20:31:34.391036+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"SVP of Finance Sandra Gurrola resigns, effective July 3, 2026","bullets":["Sandra Gurrola, SVP of Finance, resigned June 22, 2026, effective July 3, 2026.","Resignation not due to any disagreement with the Company's operations, policies, or practices.","Gurrola will provide part-time transition assistance (up to 10 hrs/week) through Q2 2026 10-Q filing.","Company has initiated search for a successor and will use outside support for finance, accounting, and reporting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-030306","json":"https://secwatch.observer/filing/0001493152-26-030306.json","markdown":"https://secwatch.observer/filing/0001493152-26-030306.md","text":"https://secwatch.observer/filing/0001493152-26-030306.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000149315226030306/0001493152-26-030306-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000149315226030306/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T20:31:34.391036+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}